Journal of the National Cancer Institute

CRISPR/Cas9 technology to inactivate cancer mutations

As for many other biomedical and biotechnology disciplines, the genome scissor "CRISPR/Cas9" also opens up completely new possibilities for cancer research. Scientists of the National Center for Tumor Disease (NCT), the German ...

Aug 31, 2016
popularity0 comments 0

New findings concerning hereditary prostate cancer

It is a well-known fact that men with a family history of prostate cancer run an increased risk of developing the disease. The risk for brothers of men with prostate cancer is doubled. But a doubled risk of what, exactly? ...

Jul 11, 2016
popularity3 comments 0